Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care

Intensive Care Medicine

Volumn 24, Issue 3, 1998, Pages 206-216

  Vincent, J L ^a   Anaissie, E ^a   Bruining, H ^a   Demajo, W ^a   El Ebiary, M ^a   Haber, J ^a   Hiramatsu, Y ^a   Nitenberg, G ^a   Nystrom P O ^a   Pittet, D ^a   Rogers, T ^a   Sandven, P ^a   Sganga, G ^a   Schaller, M D ^a   Solomkin, J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Amphotericin B; Candida; Fluconazole; Intensive care unit

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE;

CANDIDIASIS; CHILL; DISEASE PREDISPOSITION; FEVER; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HOSPITAL INFECTION; HUMAN; HYPOKALEMIA; HYPOTENSION; INFECTION RISK; INTENSIVE CARE; INTRAVASCULAR CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NAUSEA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; REVIEW; RISK FACTOR; VOMITING;

ANTIFUNGAL AGENTS; CANDIDIASIS; CAUSALITY; CROSS INFECTION; EUROPE; FUNGEMIA; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; POPULATION SURVEILLANCE; POSTOPERATIVE COMPLICATIONS; UNITED STATES;

EID: 7144226608     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050552     Document Type: Review

References (81)

1. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91 (Suppl 3B): 72S-75S
2. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29 (Suppl A): 19-24
3. Beck-Sagué C. Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 167: 1247-1251
4. Bodey GP (1993) Hematogenous and major organ candidiasis. In: Bodey GP (ed) Candidiasis: Pathogenesis, diagnosis and treatment. Raven Press. New York, pp 279-329
5. Franklin C, Metry M (1992) Life-threatening Candida infections in the intensive care unit. J Intensive Care Med 7: 127-137
6. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T et al. (1991) Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med 91 (Suppl 3B): 86S-89S
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16: 128-140
8. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoine M-H, Wolff M, Spencer RC, Hemmer MD (1995) The prevalence of nosocomial infection in intensive care units in Europe (EPIC). JAMA 274: 639-644
9. Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149: 2226-2228
10. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG (1994) Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med 154: 2093-2097
11. Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy. Rev Infect Dis 7: 646-655
12. Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645
13. Bross J, Talbot GH, Maislin G, Hurwits S, Strom BL (1989) Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 87: 614-620
14. Pittet D (1993) Nosocomial blood-stream infections. In: Wenzel RP (ed) Prevention and Control of Nosocomial Infections, 2nd Edn. Williams and Wilkins, Baltimore, pp 512-555
15. Edwards JE Jr (1990) Candida species. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious disease, 3rd Edn. Churchill Livingstone, New York, pp 1943-1958
16. Odds FC (1988) Candida and candidosis. Balliére Tindall, London
17. Hoeprich PD, Rinaldi MG (1989) Candidosis. In: Hoeprich PD, Jordan MC (eds) Infectious diseases, a modern treatise of infectious processes. Lippincott, Philadelphia, pp 465-481
18. Rotstein O, Pruett T, Simmons R (1986) Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. Can J Surg 29: 247-250
19. Marshall J, Christou N, Norn R, Meakins J (1988) The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 123: 309-315
20. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR (1991) Risk factors of candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 13: 211-215
21. Pittet D, Monod M, Filthuth I, Frenk E, Suter PM, Auckenthaler R (1991) Contour-clamped homogenous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 91 (Suppl 3B): 256S-263S
22. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN (1994) Investigation of the sequence of colonization and candidemia in non-neutropenic patients. J Clin Microbiol 32: 975-980
23. Solomkin JS (1993) Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. New Horizons 1: 202-213
24. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751-758
25. Alexander J, Gianotti L, Pyles T, Carey M, Babcock G (1991) Distribution of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 213: 558-567
26. Deitch EA, Bridges W, Baker J, Ma JW, Ma L, Grisham MB, Granger DN, Specian RD, Berg R (1988) Hemorrhagic shock induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104: 191-198
27. Alverdy J (1991) The effect of glucocorticoid administration on bacterial translocation. Evidence for an aquired mucosal immunodeficient state. Ann Surg 214: 719-723
28. Langer JC, Sohal SS (1992) Increased mucosal permeability alter intestinal ischemia-reperfusion injury is mediated by local tissue factors. J Pediatr Surg 27: 239-241
29. Salzman AL, Wollert PS, Wang H, Menconi MJ, Youssef ME, Compton CC, Fink MP (1993) Intraluminal oxygenation ameliorates ischaemia/reperfusion-induced gut mucosal hyperpermeability in pigs. Cire Shock 40: 37-46
30. Gianotti L, Alexander J, Fukushima R, Childress C (1993) Translocation of Candida albicans is related to the blood flow of individual intestinal villi. Circ Shock 40: 250-257
31. Spaeth G, Gottwald T, Specian RD, Mainous MR, Berg RD, Deitch EA (1994) Secretory immunoglobulin A, intestinal mucin and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg 220: 798-808
32. Sganga G, Gangeri G, Montemagno S, Castagneto M (1995) Prevention of translocation - prevention of multiple organ system failure. In: Mutz NJ, Koller W, and Benzer H (eds) Proceedings of the 7th European Congress on Intensive Care Medicine. Innsbruck, Austria, June 14-17 1994. Monduzzi Editore S. p. A., Bologna, pp 93-101
33. Burnie JP, Odds FC, Lee W, Webster C, Williams JD (1985) Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. BMJ 290: 746-748
34. Vaudry WL, Tierney AJ, Wenman WM (1988) Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis 158: 1375-1379
35. Matthews R, Burnie J (1989) Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis. BMJ 298: 364-375
36. Stevens DA, Odds FC, Scherer S (1990) Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 12: 258-266
37. Romano F, Ribera G, Giuliano M (1994) A study of a hospital cluster of systemic candidosis using DNA typing methods. Epidemiol Infect 112: 393-398
38. Rangel-Frausto MS, Martin MA, Saiman L, Blumberg H, Paterson JE, Pfaller MA, Wenzel RP, and the NEMIS study group (4-7 October 1994) High prevalence of Candida spp. on hands of healthcare workers in surgical and neonatal intensive care units: a multicenter study. Presented at 34th ICAAC, Orlando, Florida, USA, Abstract J106
39. Rex JH, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE, Washburn RG, Scheld M, Karchmer AW, Dine AP, Levenstein MJ, Webb CD (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331: 1325-1330
40. Solomon SL, Khabbaz RF, Parker RH, Bodey GP (1984) An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 149: 98-102
41. Weems JJ Jr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL (1987) Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 25: 1029-1032
42. Lee W, Burnie JP, Matthews RC, Oppenheim BO, Damani NN (1991) Hospital outbreaks with yeasts. J Hosp Infect 18 (Suppl A): 237-249
43. Isenberg DD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH (1989) Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 27: 2426-2428
44. Pittet D, Garbino J (1995) Fungal infections in the critically ill. Curr Opin Crit Care 1: 369-380
45. Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JEJ, Wagener MW, Yu LV (1994) Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 101: 1302-1309
46. Anaissie E, Solomkin JS (1994) Fungal Infection. In: Care of the surgical patient. Scientific American Medical, New York, pp 1-19
47. Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149: 2349-2353
48. Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F (1989) Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64: 2030-2034
49. Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditti M, Mandelli F (1993) Fungemia in patients with leukemia. Am J Med Sci 306: 225-232
50. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 26: 429-432
51. Pappu-Katikaneni H, Rao KP, Banister E (1990) Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 33: 20-23
52. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital. Epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15: 414-421
53. Giuliano M, Barza M, Jacobus NV, Gorbach SL (1987) Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 31: 202-206
54. Kennedy MJ, Volz PA (1985) Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouradia 23: 265-273
55. Samonis G, Anaissie EJ, Bodey GP (1990) Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 34: 2420-2422
56. Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP (1993) Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 37: 51-53
57. Ellis CA, Spivack ML (1967) The significance of candidemia. Ann Intern Med 67: 511-513
58. Toala P, Schroeder SA, Daly AK, Finland M (1970) Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med 126: 983-989
59. Edwards JE Jr (1991) Invasive Candida infections - evolution of a fungal pathogen. N Engl J Med 324: 1060-1062
60. Bodey GP (1993) Antifungal agents. In: Bodey GP (ed) Candidiasis: Pathogenesis, diagnosis and treatment. Raven Press, New York, pp 371-406
61. Solomkin JS, Flohr A, Simmons RL (1982) Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg 195: 177-185
62. Medoff G (1987) Controversial areas in antifungal chemotherapy: short-course and combination therapy with amphotericin B. Rev Infect Dis 9: 403-407
63. Khoo SH, Bond J, Denning DW (1994) Administering amphotericin B - a practical approach. J Antimicrob Chemother 33: 203-213
64. Lopes-Berestein G, Hopfer RL, Mehta R, Mehta K, Hersh EM, Juliano RL (1984) Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis 150: 278-283
65. Lopes-Berestein G, Fainstein V, Hopfer RL, Mehta K, Sullivan MP, Keating M, Juliano RL (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer. J Infect Dis 151: 704-710
66. Garbino J, Pittet D (1997) Candida infections in the ICU. Clin Intensive Care 8: 187-200
67. Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 101: 170-176
68. Anaissie EJ, Darouiche R, Mera J, Gentry L, Abi-Said D, Bodey GP (1996) Management of invasive candidal infections: results of a prospective randomized multicenter study of fluconazole versus amphotericin B and review of literature. Clin Infect Dis 23: 964-972
69. Kaufmann CA, Bradley SF, Ross SC, Weber DR (1991) Hepatosplenic candidiasis. Successful treatment with fluconazole. Am J Med 91: 137-141
70. Anaissie EJ, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A (1991) Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 91: 142-150
71. British Society for Antimicrobial Chemotherapy (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20: 522-528
72. Pittet D, Anaissie E, Solomkin JS (1996) When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent J-L (ed) Yearbook of Intensive Care and Emergency Medicine 1996. Springer, Berlin Heidelberg, pp 567-577
73. Singh N, Mieles L, Yu VL, Gayowski T (1993) Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 17: 906-908
74. Mora NP, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, Husherg BS, Klintmalm GB (1991) Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc 23: 1528-1530
75. Tollemar J, Ringden O, Andersson S, Sundberg B, Ljungman P, Tyden G (1993) Randomized double-blind study of liposomal amphotericin B (AmBisome®) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 12: 577-582
76. Kung N, Fisher N, Gunson B, Hastings M, Mutimer D (1995) Fluconazole prophylaxis for high-risk liver transplant recipients. Lancet 345: 1234-1235
77. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Lngl J Med 326: 845-851
78. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H et al. (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled double-blind multicenter trial. Ann Intern Med 118: 495-503
79. Bodey GP, Anaissie EJ, Elting LS, Esstey E, O'Brien S, Kantarjian H (1994) Antifungal prophylaxis during remission induction therapy for acute leukemia. Fluconazole versus intravenous amphotericin B. Cancer 73: 2099-2106
80. Meunier F, Aoun M, Janssens M, Dekoster C, Paesmans M (1991) Chemoprophylaxis of fungal infections in granulocytopenic patients using fluconazole vs oral amphotericin B. Drug Invest 3: 258-265
81. Ellis ME, Clink H, Ernst P, Halim MA, Padmos A, Spence D et al. (1994) Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 13: 3-11